Early Study Links Mothers’ Education Level to Telomere Length in Newborns
A small study of new mothers suggests that not having graduated from high school may impact the likelihood of babies being born with shortened telomeres.
University of California San Francisco
Give to UCSF
Illuminating Depression’s Circuitry
If depression is caused by flawed brain circuitry, it may be possible to shift that circuitry toward healthy neural processing instead. UCSF researchers hope to map and correct aberrant neural behavior to cure mood disorders.
Affordable Care Act Will Spur California Health Care Workforce to Develop New Leadership, Flexibility and People Skills
As health care shifts away from a fee-for-service model as a result of the ACA, health care workers in California will be called upon to develop new skills and fill new roles, according to a study led by UCSF researchers.
How an Approach Called ‘Shock and Kill’ Could Cure HIV
HIV can lurk for a lifetime in the body, so to truly cure patients, scientists are trying to find ways to target these HIV reservoirs in a strategy known as “shock and kill.”
$20M Grant from amfAR Funds Institute for HIV Cure Research
In a bid to end the worst epidemic in modern times, the Foundation for AIDS Research (amfAR) is funding an ambitious effort based in San Francisco to eliminate the human immunodeficiency virus (HIV) from those who are infected.
Swaziland Likely To Be First To Eliminate Malaria In Southern Africa
The Malaria Elimination Group, an independent international advisory group on malaria elimination convened by the Global Health Group at the University of California, San Francisco (UCSF), gathered in the Ezulwini Valley for its tenth meeting to celebrate Swaziland’s achievements. The meeting was opened on November 16, 2015 by Swaziland’s Minister of Health, Honorable Sibongile Ndlela-Simelane.
Immunotherapy For Type 1 Diabetes Deemed Safe In First U.S. Trial
In the first U.S. safety trial of a new form of immunotherapy for type 1 diabetes, patients experienced no serious adverse reactions after receiving infusions of as many as 2.6 billion cells that had been specially selected to protect the body’s ability to produce insulin.
Warm Temperatures Worsen Cardiovascular Disease but not Diabetes Risk in Mice
A new study led by UCSF researchers has found that mice who spend too much time in their thermal “comfort zone” while gorging on fatty foods more than double their risk of developing cardiovascular disease compared to mice who stayed cool while eating the same diet.
Expensive Drugs That Cure Hepatitis C Are Worth The Cost, Even At Early Stages Of Liver Fibrosis
It is worthwhile to give patients expensive new drugs that can cure their hepatitis C much earlier than some insurers are now willing to pay for them, according to a UCSF study.
Sensory Illusion Causes Cells to Self-Destruct
UCSF researchers has discovered that single-celled yeast have sensory biases that can be hacked by a carefully engineered illusion, a finding that could be used to develop new approaches to fighting diseases such as cancer.
Gunshot Survivors in High-Crime Community Face Elevated Risk of Early Death, Study Shows
One in 20 survivors of gunshot violence in an urban area with high crime died within five years, mainly by homicide, according to the results of a study that tracked patients after hospital discharge.
Working Up A Sweat May Protect Men From Lethal Prostate Cancer
A study that tracked tens of thousands of midlife and older men for more than 20 years has found that vigorous exercise and other healthy lifestyle habits may cut their chances of developing a lethal type of prostate cancer by up to 68 percent.
Human Gene Prevents Regeneration in Zebrafish
UCSF researchers have found a human gene that could one day allow physicians to correct congenital deformities, regrow damaged fingers, or even mend a broken heart.
Skin Must Develop Tolerance to ‘Good’ Bacteria Early In Life, Says New Study
A wave of specialized immune cells entering the skin in early life may induce tolerance to the hundreds of species of so-called friendly bacteria that live on the surface of the body.
New Sean N. Parker Autoimmune Research Laboratory is Launched at UCSF
A $10 million gift from The Parker Foundation, founded by Silicon Valley entrepreneur and philanthropist Sean Parker, will establish a new research laboratory within the UCSF Diabetes Center devoted to understanding autoimmunity.
